Skip to main content
Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1

Fig. 5

RNA expression levels of IDO, CTLA-4 and PD-L1 in 4T1 (A) and MDA-MB-231 B cells under different treatments. STAT1 and STAT1 phosphorylation and PD-L1 protein expression levels in 4T1 (C) and MDA-MB-231 D cells under different treatments. E Flow cytometry of PD-L1 expression in breast cancer cells under different treatments

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us